Diabetes UK Annual Professional Conference, Liverpool Phenotypic features of patients with Type 2 diabetes at increased risk of severe hypoglycemic events occurring before or after cardiovascular events
E Standl , SR Stevens , Y Lokhnygina , JB Buse , AP Maggioni , RJ Mentz , AF Hernandez and RR Holman
Diabetic Medicine 2019;36:Suppl 1:131 [Abstract]
American College of Cardiology (ACC) Annual Scientific Sessions, New Orleans Patients with diabetes and peripheral arterial disease: Results from the EXSCEL trial
Anish Badjatiya, Peter Merrill, John Buse, Shaun Goodman, Brian Katona, Nayyar Iqbal, Peter Ohman, Neha Pagidipati, Naveed Sattar, Rury Holman, Adrian Hernandez, Robert J. Mentz, Manesh Patel, Schuyler Jones
Journal of the American College of Cardiology 2019;73:9 (Suppl 1):2040 [Abstract]
American College of Cardiology (ACC) Annual Scientific Sessions, New Orleans Increased risk of severe hypoglycemic events before and after cardiovascular events in type 2 diabetes: Validation of a novel concept
Eberhard Standl, Susanna Stevens, Yuliya Lokhnygina, John Buse, Aldo Maggioni, Robert Mentz, Ambady Ramachandran, Adrian Hernandez, Rury Holman
Journal of the American College of Cardiology 2019;73:9 (Suppl 1):24 [Abstract]
55th Annual Meeting of the European Association for the Study of Diabetes, Barcelona Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
R.L. Coleman, A.M. Gray, D.K. McGuire, R.R. Holman
Diabetologia 2019;62:(Supp 1):S152 [Abstract]
2018
54th Annual Meeting of the European Association for the Study of Diabetes, Berlin Potential impact of differential drop-in of open-label diabetes medications in EXSCEL
J.B. Buse, M.A. Bethel, R.A. Patel, S.R. Stevens, S.M. Gustavson, Y. Lokhnygina, A.F. Hernandez, R.R.Holman, for the EXSCEL Study Group
Diabetologia 2018;61:(Suppl 1):S21-S22 [Abstract]
54th Annual Meeting of the European Association for the Study of Diabetes, Berlin Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
A.F. Hernandez, M.A. Bethel , G.L. Bakris , P. Merrill, S.M. Gustavson, B.G. Katona, P. Ohman, Y. Lokhnygina, R.J. Mentz, R.R. Holman
Diabetologia 2018;61:(Suppl 1):S38 [Abstract]
54th Annual Meeting of the European Association for the Study of Diabetes, Berlin Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
F. Becker, H.Dakin, S.D.Reed, Y.Li, J. Leal, S.M. Gustavson, B.Kartman, E.Wittbrodt, A.M. Gray, A.F.Hernandez, R.R. Holman
Diabetelogia 2018;61:(Suppl 1):S366 [Abstract]
54th Annual Meeting of the European Association for the Study of Diabetes, Berlin Changes in serum calcitonin concentrations and incidence of adjudicated medullary thyroid carcinoma in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
B. Katona, M.A. Bethel, R. Patel, V.P. Thompson, S.M. Gustavson, P. Ohman, N. Iqbal, J.B.Buse, A.F. Hernandez, R.R.Holman
Diabetelogia 2018;61:(Suppl 1):S376 [Abstract]
54th Annual Meeting of the European Association for the Study of Diabetes, Berlin Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL
S.D. Reed, Y. Li, H. Dakin, F. Becker, J. Leal, S.M. Gustavson, B. Kartman, E. Wittbrodt, R.J. Mentz, N.J. Pagidipati, M.A. Bethel, A.M. Gray, R.R. Holman, A.F. Hernandez
Diabetelogia 2018;61:(Suppl 1):S426 [Abstract]
European Society of Cardiology (ESC) Congress 2018, Munich Effects of once weekly exenatide on clinical outcomes in the subgroup of patients with preexisting cardiovascular disease: insights from EXSCEL
R.J. Mentz, V.P. Thompson, S.M. Gustavson, N. Iqbal, P. Ohman, R.R. Holman, A.F. Hernandez
European Heart Journal 2018;39:(Suppl 1):1082 [Abstract]
American Diabetes Association (ADA) Conference, Orlando Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
M. ANGELYN BETHEL, ROBERT J. MENTZ, PETER MERRILL, JOHN B. BUSE, JULIANA C. CHAN, SHAUN G. GOODMAN, NAYYAR IQBAL, NELI JAKUBONIENE, BRIAN G. KATONA, YULIYA LOKHNYGINA, RENATO D. LOPES, ALDO P. MAGGIONI, PETER K. OHMAN, NEIL R. POULTER, AMBADY RAMACHANDRAN, TSVETALINA TANKOVA, BERNARD ZINMAN, ADRIAN F. HERNANDEZ, RURY R. HOLMAN
Diabetes 2018;67:(Suppl 1):522-P [Abstract]
American Diabetes Association (ADA) Conference, Orlando EXSCEL-Once-Weekly Exenatide Reduces Medical Resource Utilization in Patients with Type 2 Diabetes Mellitus
SHELBY D. REED, YANHONG LI, HELEN A. DAKIN, FRAUKE BECKER, JOSE LEAL, STEPHANIE GUSTAVSON, BERNT KARTMAN, ERIC T. WITTBRODT, ROBERT J. MENTZ, NEHA PAGIDIPATI, M. ANGELYN BETHEL, ALASTAIR M. GRAY, RURY R. HOLMAN and ADRIAN F. HERNANDEZ
Diabetes 2018;67:(Suppl 1):1319-P [Abstract]
American Diabetes Association (ADA) Conference, Orlando Impact of SGLT2 Inhibitors (SGLT2i) on Cardiovascular (CV) Risk and Estimated Glomerular Filtration Rate (eGFR) in the EXSCEL Placebo Group
LINDSAY CLEGG, HIDDO L. HEERSPINK, ROBERT C PENLAND, WEIFENG TANG, DAVID W BOULTON, SRINIVAS BACHINA, ROBERT D FOX, PETER FENICI, MARCUS THURESSON, ROBERT J MENTZ, ADRIAN F HERNANDEZ, M ANGELYN BETHEL, RURY R HOLMAN
Diabetes 2018;67:(Suppl 1):130-LB [Abstract]
Diabetes Congress of the German Diabetes Association, Berlin Effects of exenatide on cardiovascular outcomes in patients with type 2 diabetes mellitus: results of the EXSCEL study
Hanefeld M on behalf of EXSCEL Study Group
Diabetology and Metabolism 2018;13:Suppl 1:S70 [Abstract]
14th National Conference of the Primary Care Diabetes Society, Birmingham Effects of once-weekly exenatide on clinical outcomes in the subgroup of patients with pre-existing cardiovascular disease: Insights from EXSCEL
Mentz RJ, on behalf of the EXSCEL Study Group
Diabetes and Primary Care 2018;20:Suppl A:3 [Abstract]
2017
American Heart Association (AHA) Scientific Sessions 2017, Anaheim Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial
Robert J Mentz, M. Angelyn Bethel, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Julian C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal, Aldo P Maggioni, Steven P Marso, Peter Öhman, Neha J Pagidipati, Neil Poulter, Ambady Ramachandran, Bernard Zinman, Rury R Holman, Adrian F Hernandez, on behalf of the EXSCEL Study Group
Circulation 2017;136:24: [Abstract]
2016
American Diabetes Association (ADA) Conference, New Orleans Baseline Characteristics of Patients Enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
ROBERT MENTZ, M ANGELYN BETHEL, STEPHANIE GUSTAVSON, VIVIAN THOMPSON, JOHN B BUSE, JULIANA CHAN, ALDO P MAGGIONI, STEVEN P MARSO, PETER OHMAN, NEIL POULTER, AMBADY RAMACHANDRAN, BERNARD ZINMAN, NAYYAR IQBAL, ADRIAN F HERNANDEZ, RURY R HOLMAN
Diabetes 2016;65:(Suppl 1):1039-P [Abstract]
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857240 Email: dtu@dtu.ox.ac.uk
